According to studies performed in different populations, PALB2 mutation frequencies in familial breast cancer cases range between 0.6 and 2.7% [1,10,15], while the cumulative average risk reaches approximately 35% by the age of 70, which is similar to the cumulate average risk conferred by germline BRCA2 mutations [1]. Here, PALB2 is linked to breast carcinoma.